Tumor vasculature targeting and imaging in living mice with reduced graphene oxide

Biomaterials

Volumn 34, Issue 12, 2013, Pages 3002-3009

  Shi, Sixiang ^a   Yang, Kai ^b   Hong, Hao ^a   Valdovinos, Hector F ^c   Nayak, Tapas R ^a   Zhang, Yin ^c   Theuer, Charles P ^d   Barnhart, Todd E ^c   Liu, Zhuang ^b   Cai, Weibo ^a,c,e  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b SOOCHOW UNIVERSITY   (China)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d TRACON Pharmaceuticals Inc   (United States)

^e UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Cancer; CD105 (endoglin); Nanomedicine; Positron emission tomography (PET); Reduced graphene oxide (RGO); Tumor angiogenesis

Indexed keywords

BREAST TUMOR; CANCER; ENDOGLIN; EX-VIVO; IN-VITRO; IN-VIVO; NON-TARGETED; PHOTOTHERMAL THERAPY; REDUCED GRAPHENE OXIDES; THERANOSTIC AGENTS; TUMOR ANGIOGENESIS; TUMOR UPTAKE; TUMOR VASCULATURE;

FLOW CYTOMETRY; GRAPHENE; MAMMALS; MEDICAL IMAGING; MEDICAL NANOTECHNOLOGY; POSITRON EMISSION TOMOGRAPHY;

TUMORS;

2 (4 ISOTHIOCYANATOBENZYL) 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID; ACETIC ACID DERIVATIVE; ANTIBODY; COPPER 64; GRAPHENE OXIDE; TRC 105; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; DRUG CONJUGATION; DRUG STABILITY; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ANIMALS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; GRAPHITE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; POSITRON-EMISSION TOMOGRAPHY;

MURINAE; MUS;

EID: 84873436907     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.01.047     Document Type: Article

References (46)

1. Novoselov K.S., Geim A.K., Morozov S.V., Jiang D., Zhang Y., Dubonos S.V., et al. Electric field effect in atomically thin carbon films. Science 2004, 306:666-669.
2. Geim A.K., Novoselov K.S. The rise of graphene. Nat Mater 2007, 6:183-191.
3. Service R.F. Materials science. Carbon sheets an atom thick give rise to graphene dreams. Science 2009, 324:875-877.
4. Pumera M. Graphene-based nanomaterials and their electrochemistry. Chem Soc Rev 2010, 39:4146-4157.
5. Li X., Wang X., Zhang L., Lee S., Dai H. Chemically derived, ultrasmooth graphene nanoribbon semiconductors. Science 2008, 319:1229-1232.
6. Huang X., Yin Z., Wu S., Qi X., He Q., Zhang Q., et al. Graphene-based materials: synthesis, characterization, properties, and applications. Small 2011, 7:1876-1902.
7. Novoselov K.S., Fal'ko V.I., Colombo L., Gellert P.R., Schwab M.G., Kim K. A roadmap for graphene. Nature 2012, 490:192-200.
8. Feng L., Liu Z. Graphene in biomedicine: opportunities and challenges. Nanomedicine (Lond) 2011, 6:317-324.
9. Yang K., Feng L., Shi X., Liu Z. Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev 2012, 42:530-547.
10. Zhang Y., Nayak T.R., Hong H., Cai W. Graphene: a versatile nanoplatform for biomedical applications. Nanoscale 2012, 4:3833-3842.
11. Yang K., Wan J., Zhang S., Zhang Y., Lee S.T., Liu Z. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano 2011, 5:516-522.
12. Yang K., Wan J., Zhang S., Tian B., Zhang Y., Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 2012, 33:2206-2214.
13. Davis M.E., Chen Z.G., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008, 7:771-782.
14. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4:145-160.
15. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
16. Yang K., Hu L., Ma X., Ye S., Cheng L., Shi X., et al. Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv Mater 2012, 24:1868-1872.
17. Ruoslahti E., Bhatia S.N., Sailor M.J. Targeting of drugs and nanoparticles to tumors. J Cell Biol 2010, 188:759-768.
18. Cai W., Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small 2007, 3:1840-1854.
19. Hong H., Zhang Y., Sun J., Cai W. Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today 2009, 4:399-413.
20. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
21. Seon B.K., Haba A., Matsuno F., Takahashi N., Tsujie M., She X., et al. Endoglin-targeted cancer therapy. Curr Drug Deliv 2011, 8:135-143.
22. Fonsatti E., Nicolay H.J., Altomonte M., Covre A., Maio M. Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovasc Res 2010, 86:12-19.
23. Zhang Y., Yang Y., Hong H., Cai W. Multimodality molecular imaging of CD105 (Endoglin) expression. Int J Clin Exp Med 2011, 4:32-42.
24. Dallas N.A., Samuel S., Xia L., Fan F., Gray M.J., Lim S.J., et al. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res 2008, 14:1931-1937.
25. Rosen L.S., Hurwitz H.I., Wong M.K., Goldman J., Mendelson D.S., Figg W.D., et al. A phase I first-in-human study of TRC105 (Anti-Endoglin Antibody) in patients with advanced cancer. Clin Cancer Res 2012, 18:4820-4829.
26. Gambhir S.S. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002, 2:683-693.
27. 18F-based radiotracers. Am J Nucl Med Mol Imaging 2012, 2:55-76.
28. 18F-FDG PET in sarcoma treatment response imaging. Am J Nucl Med Mol Imaging 2011, 1:47-53.
29. 11C-acetate. Am J Nucl Med Mol Imaging 2012, 2:33-47.
30. Liu X., Tao H., Yang K., Zhang S., Lee S.T., Liu Z. Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors. Biomaterials 2011, 32:144-151.
31. Hong H., Yang K., Zhang Y., Engle J.W., Feng L., Yang Y., et al. In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS Nano 2012, 6:2361-2370.
32. 89Zr and IRDye 800CW. Am J Transl Res 2012, 4:333-346.
33. 89Zr and IRDye 800CW. Mol Pharmacol 2012, 9:2339-2349.
34. 66Ga-labeled nano-graphene. Biomaterials 2012, 33:4147-4156.
35. Zhang Y., Hong H., Engle J.W., Yang Y., Barnhart T.E., Cai W. Positron emission tomography and near-infrared fluorescence imaging of vascular endothelial growth factor with dual-labeled bevacizumab. Am J Nucl Med Mol Imaging 2012, 2:1-13.
36. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
37. Robinson J.T., Tabakman S.M., Liang Y., Wang H., Casalongue H.S., Vinh D., et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc 2011, 133:6825-6831.
38. 18F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challenge. Am J Nucl Med Mol Imaging 2011, 1:63-64.
39. Vach W., Høilund-Carlsen P.F., Fischer B.M., Gerke O., Weber W. How to study optimal timing of PET/CT for monitoring of cancer treatment. Am J Nucl Med Mol Imaging 2011, 1:54-62.
40. 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA. PLoS One 2011, 6:e28005.
41. 64Cu-labeled antibody. Nucl Med Biol 2011, 38:29-38.
42. Liu Z., Cai W., He L., Nakayama N., Chen K., Sun X., et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2007, 2:47-52.
43. Cai W., Chen K., Li Z.B., Gambhir S.S., Chen X. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J Nucl Med 2007, 48:1862-1870.
44. Cai W., Chen X. Preparation of peptide conjugated quantum dots for tumour vasculature targeted imaging. Nat Protoc 2008, 3:89-96.
45. Cai W., Chen X. Multimodality molecular imaging of tumor angiogenesis. J Nucl Med 2008, 49(Suppl. 2):113S-128S.
46. Cai W., Shin D.W., Chen K., Gheysens O., Cao Q., Wang S.X., et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 2006, 6:669-676.